NovaBridge Biosciences Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

215.11M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	632.00K	2.18M	-
Dec 31, 2022	-1.55M	-15.40M	-
Dec 31, 2021	13.85M	-222.30M	-94.14%
Dec 31, 2020	236.15M	231.84M	5,381.19%
Dec 31, 2019	4.31M	-3.51M	-44.90%
Dec 31, 2018	7.82M	6.04M	340.20%
Dec 31, 2017	1.78M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Arcturus Therapeutics Holdings	54.71M
Tonix Pharmaceuticals Holding	17.56M
MediWound	16.96M
Caribou Biosciences	11.20M
Milestone Pharmaceuticals	1.78M
Cartesian Therapeutics	1.78M

Revenue Rankings

NBP News

7 days ago - NovaBridge Biosciences Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
14 days ago - NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference - GlobeNewsWire
4 weeks ago - NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value - GlobeNewsWire
5 weeks ago - NovaBridge Biosciences Slides: Corporate presentation - Filings
7 weeks ago - NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
7 weeks ago - NovaBridge Biosciences Earnings release: Q4 2025 - Filings
7 weeks ago - NovaBridge Biosciences Annual report: Q4 2025 - Filings
2 months ago - NovaBridge had ‘productive’ FDA meeting on potential gastric cancer treatment - TheFly

More News